Back | Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
Even though we are on a slight upswing | tredenwater2 | investorshub | 07/14/2024 3:54:19 PM |
Thanks, I normally take note of what I | sab63090 | investorshub | 07/14/2024 2:36:52 PM |
True statement/Opinion, | Newco76 | investorshub | 07/14/2024 12:13:00 PM |
Dr Ruth, your go to passed | tradersbend | investorshub | 07/14/2024 11:49:01 AM |
Blocks >-5K | XenaLives | investorshub | 07/14/2024 5:37:36 AM |
Blocks >=1K | XenaLives | investorshub | 07/14/2024 5:26:32 AM |
What a horrible day for America! | Thehubby | investorshub | 07/14/2024 4:28:43 AM |
https://www.fiercebiotech.com/biotech/anavex-touts-very-large-phase-3-win-for-re | kund | investorshub | 07/14/2024 4:12:07 AM |
Rett and AD goal posts...during some research. Endpoints | ExtremelyBullishZig | investorshub | 07/14/2024 3:50:08 AM |
You should care. Since my last response was | ExtremelyBullishZig | investorshub | 07/14/2024 3:49:09 AM |
Whom exactly was the media? | Rubyred77 | investorshub | 07/14/2024 3:32:25 AM |
ADCS-ADL is, according to the FDA and Anavex, | Hoskuld | investorshub | 07/14/2024 12:55:38 AM |
There is plenty of evidence...one big one is | Hosai | investorshub | 07/13/2024 11:42:21 PM |
I think Anavex HAS been honest about their | kund | investorshub | 07/13/2024 10:07:18 PM |
There is plenty of evidence...one big one is | ExtremelyBullishZig | investorshub | 07/13/2024 9:36:27 PM |
Sorry, EBZ, I missed your note here. | Hoskuld | investorshub | 07/13/2024 9:19:14 PM |
I think the avxl on the pill looks cool. | tradeherpete | investorshub | 07/13/2024 9:15:51 PM |
Lol. But there's no pill for foolish. | frrol | investorshub | 07/13/2024 8:45:18 PM |
Ill entertain Kunds griping about pill labeling for | Rubyred77 | investorshub | 07/13/2024 6:49:13 PM |
Hopefully A2-73 will be effective for Aspergers. | Investor2014 | investorshub | 07/13/2024 6:36:19 PM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...
NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsyc...